Prostatis Group’s Innovator Equity Defined Protection ETF - 1 Yr February ZFEB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$457K Sell
18,016
-33,329
-65% -$849K 0.12% 109
2025
Q4
$1.3M Sell
51,345
-38,678
-43% -$972K 0.31% 65
2025
Q3
$2.25M Sell
90,023
-16,235
-15% -$400K 0.56% 47
2025
Q2
$2.59M Buy
106,258
+95,326
+872% +$2.28M 0.74% 39
2025
Q1
$259K Buy
+10,932
New +$260K 0.08% 132

Other funds holding ZFEB

Prostatis Group's ZFEB Position: Q1 2026 in Review

Prostatis Group reduced its Innovator Equity Defined Protection ETF - 1 Yr February (ZFEB) stake by 65% in Q1 2026, selling an estimated $849K and leaving 18,016 shares worth $457K. The position accounts for 0.12% of the portfolio, ranked #109.

Prostatis Group first reported a position in ZFEB in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.59M in Q2 2025. 98 funds tracked by Wall St. Rank hold ZFEB as of Q1 2026.

  • Prostatis Group held 18,016 shares of Innovator Equity Defined Protection ETF - 1 Yr February worth $457K as of Q1 2026.
  • Prostatis Group sold 33,329 Innovator Equity Defined Protection ETF - 1 Yr February shares in Q1 2026, an estimated $849K.
  • Innovator Equity Defined Protection ETF - 1 Yr February made up 0.12% of Prostatis Group's portfolio in Q1 2026, its #109 holding.
  • Prostatis Group first reported a position in Innovator Equity Defined Protection ETF - 1 Yr February in Q1 2025 and has held it in 5 quarters since.
  • Prostatis Group's Innovator Equity Defined Protection ETF - 1 Yr February position peaked at $2.59M in Q2 2025.
  • 98 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 1 Yr February as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.